Preliminary study on the E-liquid and aerosol on the neurobehavior of C. elegans
Environment International · 2023
DOI: 10.1016/j.envint.2023.108180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environment International, 2023. Verfasst von Yanting Pang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Neurotoxicity Syndromes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
E-cigarettes, also known as electronic nicotine delivery systems (ENDS), are mainly used among adolescents and young adults. Similar to traditional cigarettes, different concentrations of nicotine are also added to E-cigarette's liquid (E-liquid), but due to the supplementation of chemicals such as propylene glycol (PG), vegetable glycerin (VG) and flavors, it is difficult to determine the risk after using E-cigarettes. And given to the specificity of the aerosol particle composition and atomization process of E-cigarettes, it is necessary to assess the neurotoxic effects of long-term E-cigarettes use. In this study, two commercial nicotine-containing (5%) and nicotine-free E-liquids were diluted to investigate the neurobehavioral changes and addictive tendencies of developing C. elegans after sub-chronic exposure to E-liquid. The results showed that sub-chronic exposure of E-liquid could lead to impaired growth and development of nematodes, abnormal general neuromotor behavior and advanced learning and memory behavior, and nicotine-containing E-liquid could also lead to increased addiction tendency of nematodes. Although the damage effect of nicotine free E-liquid is smaller than that of the nicotine-containing group, its toxic effect cannot be ignored. Further analysis of the neurotoxicity mechanism found that redox imbalance-mediated mitochondrial stress and aging may be important causes of E-liquid-induced biological damage. The biosafety of e-cigarette aerosols was also included in the assessment. The study found that the heated atomization process did not alter the E-liquid components, and E-cigarette aerosols still have the effect of interfering with the growth and development of nematodes and neurobehavior, and its addictive nature is also of concern. This study can provide new ideas for future studies on the neurotoxic effects and safety assessment of the E-cigarettes, and provide theoretical reference for the study on the injury mechanism of E-cigarettes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China. Electronic address: zhangting@seu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Pang, Y., Li, M., Li, F., Lei, J., & Zhang, T. (2023). Preliminary study on the E-liquid and aerosol on the neurobehavior of C. elegans. Environment International. https://doi.org/10.1016/j.envint.2023.108180
Vancouver
Pang Y, Li M, Li F, Lei J, Zhang T. Preliminary study on the E-liquid and aerosol on the neurobehavior of C. elegans. Environment International. 2023. doi:10.1016/j.envint.2023.108180
BibTeX
@article{Pang2023,
author = {Pang, Yanting and Li, Menghan and Li, Fuxian and Lei, Jialin and Zhang, Ting},
title = {Preliminary study on the E-liquid and aerosol on the neurobehavior of C. elegans},
journal = {Environment International},
year = {2023},
doi = {10.1016/j.envint.2023.108180}
}
EUVIMED